Finland· FI-REL-REL10927
Typherix
A typhus, gereinigtes polysaccharid-antigen product containing salmonella typhi (ty2) bacteria, vi polysaccharide, registered in Finland by GlaxoSmithKline Biologicals SA. The same ATC class is registered in 9 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Typhus, gereinigtes polysaccharid-antigen is registered in 9 of 19 countries.
Countries holding a registration under ATC J07AP03 (typhus, gereinigtes polysaccharid-antigen), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 5 of them publish a price we can compare per daily dose
Typhus, gereinigtes polysaccharid-antigen · ATC J07AP03
9 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
The record
At a glance
Fimea (Finland)- Active substance
- Salmonella typhi (Ty2) bacteria, Vi polysaccharide
- Manufacturer
- GlaxoSmithKline Biologicals SA
- Country
- Finland (FI)
- ATC code
- J07AP03
- ATC class
- Typhus, gereinigtes Polysaccharid-Antigen
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Typhus, gereinigtes polysaccharid-antigen in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/44765e2a-a9ec-46f7-8a2f-477a66bca0bb GET /v1/drugs/44765e2a-a9ec-46f7-8a2f-477a66bca0bb?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "injektioneste, liuos",
"route": null,
"ddd_unit": null,
"strength": "25 mikrog / 0.5 ml",
"atc_label": "lavantautipolysakkaridirokote",
"ma_number": "13888",
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": null,
"fimea_rel_id": "REL10927",
"authorised_at": "1999-06-28"
}See everything about typhus, gereinigtes polysaccharid-antigen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.